Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.

Sperber, Pia S; Brandt, Alexander U; Zimmermann, Hanna G; Bahr, Lina S; Chien, Claudia; Rekers, Sophia; Mähler, Anja; Böttcher, Chotima; Asseyer, Susanna; Duchow, Ankelien Solveig; Bellmann-Strobl, Judith; Ruprecht, Klemens; Paul, Friedemann; Schmitz-Hübsch, Tanja

Sperber, Pia S; Brandt, Alexander U; Zimmermann, Hanna G; Bahr, Lina S; Chien, Claudia; Rekers, Sophia; Mähler, Anja; Böttcher, Chotima; Asseyer, Susanna; Duchow, Ankelien Solveig; Bellmann-Strobl, Judith; Ruprecht, Klemens; Paul, Friedemann; Schmitz-Hübsch, Tanja.

Afiliación

Sperber PS; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.
Brandt AU; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.
Zimmermann HG; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Bahr LS; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Chien C; German Center for Cardiovascular Disease (DZHK), Berlin, Germany.
Rekers S; Department of Neurology, University of California, CA, Irvine, USA.
Mähler A; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.
Böttcher C; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.
Asseyer S; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Duchow AS; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Bellmann-Strobl J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.
Ruprecht K; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany.
Paul F; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Schmitz-Hübsch T; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.

BMC Neurol ; 22(1): 479, 2022 Dec 14.

Article en En | MEDLINE | ID: mdl-36517734

Asunto(s)

Esclerosis Múltiple; Neuromielitis Óptica; Humanos; Acuaporina 4; Autoanticuerpos; Berlin; Estudios Longitudinales; Esclerosis Múltiple/diagnóstico; Glicoproteína Mielina-Oligodendrócito; Neuromielitis Óptica/diagnóstico; Estudios Observacionales como Asunto; Sistema de Registros

Palabras clave

Clinically isolated syndrome (CIS); Multiple sclerosis (MS); Myelin-oligodendrocytic-glycoprotein associated disease (MOGAD); Neuromyelitis optica spectrum disorder; Optic neuritis; Prospective observational study

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google